Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Boehringer Ingelheim Dealt New Blow In Nearly Two Years Of Review For Pradaxa In Australia

Dec 18 2012

• By Ed Lane

Related Content

Mini Sentinel Alleviates FDA Concern Over Pradaxa Bleeding Issue

Nov 02 2012

Boehringer Ingelheim's Open Letter For Pradaxa Brings Australian PBS Back Into Spotlight

Nov 03 2011

Battle Over Deferred Drug Listings In Australia: Should Cost-Effective Drugs Always Be Funded?

May 06 2011

Related Companies

Boehringer Ingelheim GmbH

Additional Topics

Australia Asia Pacific Regulation Approvals BioPharmaceutical

More from Focus On Asia

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window